Method for treatment of insulin resistance in obesity and diabetes
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Feb 10, 2004
Grant Date -
Jul 25, 2002
app pub date -
Sep 13, 2001
filing date -
Sep 13, 2000
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
Disclosed is a method to identify compounds useful for reducing insulin resistance in a patient, and particularly a patient that has insulin resistance associated with obesity and/or type II diabetes. Also disclosed is a method of reducing insulin resistance in a patient by administering a compound identified using the method of the invention, and particularly, by administering an antagonist of melanocortin stimulating hormone (MSH) biological activity.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully